Healthcare

UK Weight-Loss Jab Deaths Reach 216 As Regulator Faces Scrutiny Over Rising Toll

MHRA data shows 150,000 adverse reaction reports for GLP-1 drugs including Mounjaro and Wegovy, with 18,000 classed as serious, as annual fatalities triple in a year.

By
Distilled Post Editorial Team
Technology

China's Warehouse Robots Are Already In Britain's Supply Chains. Washington's Response Should Worry The NHS

A US ban on Chinese-made humanoid robots exposes a governance question the health service has yet to confront, even as its own appetite for automation grows.
Business

When the Treasury Talks About Borrowing, The NHS Estate Is Listening

John Healey's search for fiscal flexibility ahead of his first budget will decide whether a decade of promised capital investment in hospitals finally arrives, or is quietly redirected again.

Healthcare

View All

Government Names 159 Sites For £343m Mental Health Capital Investment

Mental Health Trusts Agree New Waiting Time Targets With NHS England In Bid To Raise Sector's Standing In Whitehall

The NHS Heat Crisis Is Not A Climate Story, It Is A Capital Story

The Innovation Fund That Admits The NHS Has An Adoption Problem

The Cyclospora Outbreak Sweeping America Should Trouble British Ministers Long After Its Headlines Fade

Business

Browse Category

When the Treasury Talks About Borrowing, The NHS Estate Is Listening

John Healey's search for fiscal flexibility ahead of his first budget will decide whether a decade of promised capital investment in hospitals finally arrives, or is quietly redirected again.

Where the Health Service's Budget Insurance Policy Went Missing

Andy Burnham's failure to install an authoritative economic team leaves the NHS exposed just as Budget day approaches.

AstraZeneca's Bristol Myers Flirtation Exposes the Bargain Between Britain and Its Pharmaceutical Champion

The reported $400bn tie-up talk says less about corporate logic than about a decade-long tension over what the NHS pays for medicine and what the UK expects in return.

The Growth Equity Gap That Reveals How Britain Really Prices Its Health Technology Ambitions

A £55m commitment to a £941m technology fund exposes the persistent scale mismatch between mainstream tech investment and the NHS's life sciences ambitions.

Technology

Browse Category

The Backdoor Precedent: What Apple's Fight With the Home Office Reveals About the State's Claim on Britain's Health Data

As Whitehall presses a technology company to weaken the security of a phone, it is simultaneously asking patients to hand over something far more sensitive than anything stored on it.

What a New Buy Now, Pay Later Regime Reveals About Who Owns the NHS Patient Relationship

Retail credit regulation and health data governance rarely share a headline, but both now turn on the same unresolved question about outsourcing the core relationship an institution exists to hold.

The AI Illusion: Silicon Valley Can’t Tame Its Tech, But the NHS is Buying It

The disclosure that leading American AI models breached outside organisations during routine testing exposes a governance vacuum that British health leaders can no longer treat as somebody else's problem.

When The Market Cannot Keep Pace: Berkshire's Digital Strategy And The Fragile Arithmetic Of NHS Productivity

A trust's candid admission that scheduling software is simply unavailable in the market reveals how much of Whitehall's efficiency planning depends on technology that has not yet been built.

We aim to expose our readers to new ideas and ways of thinking, bring new companies valuable exposure and transforming our futures with a platform that is inclusive and diverse in both content and people.
ContactPrivacy Policy
Distil MarketingArchive